Clinical Trial Update: Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and erlotinib before and after surgery in resectable pancreatic cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-08